Topiramate monotherapy for partial onset seizures

Epilepsia

Volumn 38, Issue 3, 1997, Pages 294-300

  Sachdeo, Rajesh C ^a   Reife, Ross A ^b   Lim, Pilar ^b   Pledger, Gordon ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Antiepileptic drugs; Generalized seizures; Monotherapy; Partial onset seizures; Topiramate

Indexed keywords

TOPIRAMATE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOCAL EPILEPSY; GRAND MAL EPILEPSY; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EPILEPSIES, PARTIAL; FEMALE; FRUCTOSE; HUMANS; MALE; PARESTHESIA; PLACEBOS; TREATMENT OUTCOME;

EID: 0030938774     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1997.tb01120.x     Document Type: Article

References (21)

1. Harden CL. New antiepileptic drugs. Neurology 1994;44:787-95.
2. Maryanoff BE, Nortey SO. Gardocki JF, Shank RP. Dodgson SP. Anticonvulsant O-alkyl sulfamates. 2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate and related compounds. J Med Chem 1987;30:880-7.
3. Shank RP, Gardocki JF, Vaught JL, et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia 1994;35:450-60.
4. Coulter DA, Sombati S. Delorenzo RJ. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia 1993;34(suppl 2):123.
5. 2+-induced seizure discharges in cultured hippocampal neurons. Epilepsia 1995;36(suppl 4):38.
6. Twyman RE, Brown SD, White HS. The anticonvulsant topiramate potentiates GABA-evoked chloride currents. Ann Neurol (in press).
7. Brown SD, Wolf HH, Swinyard EA, Twyman RE, White HS. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia 1993;34(suppl 2):122-3.
8. White HS, Brown SD, Skeen GA, Twyman RE. The investigational anticonvulsant topiramate potentiates GABA-evoked currents in mouse cortical neurons. Epilepsia 1995;36(suppl 4):34.
9. Seven L, Coulter DA, Sombati S, DeLorenzo RJ. Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia 1995;36(suppl 4):38.
10. Martinez-Lage J, Ben-Menachem E, Shorvon SD, et al. Double-blind, placebo-controlled trial of 400 mg/day topiramate as add-on therapy in patients with refractory epilepsy. Epilepsy Res 1995;36(suppl 3):S149.
11. Tassinari CA, Michelucci R, Chauvel P, et al. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996;37:763-8.
12. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial epilepsy. Epilepsia 1996;36:539-43.
13. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebocontrolled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996;6;1684-90.
14. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Neurology 1996;6:1678-83.
15. Pledger GW, Sahlroot JT. Alternative analyses for antiepileptic drug trials. In: French JA, Dichter MA, Leppik IE, eds. New antiepileptic drug development: preclinical and clinical aspects. New York: Elsevier Science Publishers, 1993:167-74.
16. Doose DR, Gisclon LG, Stellar SM, Riffits JM, Hills JF. The effect of food on the bioavailability of topiramate from 100- and 400-mg tablets in healthy male subjects. Epilepsia 1992;33(suppl 3):105.
17. Gisclon LG, Riffitts JM, Sica DA, Gehr T, Ruddley J. The pharmacokinetics (PK) of topiramate (T) in subjects with renal impairment (RI) as compared to matched subjects with normal renal function (NRF). Pharm Res 1993;10(suppl 10):S397.
18. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical classification of epileptic seizures. Epilepsia 1981;22:489-501.
19. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley & Sons, 1980.
20. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley & Sons, 1981.
21. Lehmann EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden Day, 1975.